319
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Subsets of rodent neurons are reported to express major histocompatibilty complex class I (MHC-I), but such expression has not been reported in normal adult human neurons. Here we provide evidence from immunolabel, RNA expression, and mass spectrometry analysis of postmortem samples that human catecholaminergic substantia nigra and locus coeruleus neurons express MHC-I, and that this molecule is inducible in human stem cell derived dopamine (DA) neurons. Catecholamine murine cultured neurons are more responsive to induction of MHC-I by gamma-interferon than other neuronal populations. Neuronal MHC-I is also induced by factors released from microglia activated by neuromelanin or alpha-synuclein, or high cytosolic DA and/or oxidative stress. DA neurons internalize foreign ovalbumin and display antigen derived from this protein by MHC-I, which triggers DA neuronal death in the presence of appropriate cytotoxic T-cells. Thus, neuronal MHC-I can trigger antigenic response, and catecholamine neurons may be particularly susceptible to T cell-mediated cytotoxic attack.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: found
          • Article: not found

          T cell receptor antagonist peptides induce positive selection.

          We have used organ culture of fetal thymic lobes from T cell receptor (TCR) transgenic beta 2M(-/-) mice to study the role of peptides in positive selection. The TCR used was from a CD8+ T cell specific for ovalbumin 257-264 in the context of Kb. Several peptides with the ability to induce positive selection were identified. These peptide-selected thymocytes have the same phenotype as mature CD8+ T cells and can respond to antigen. Those peptides with the ability to induce positive selection were all variants of the antigenic peptide and were identified as TCR antagonist peptides for this receptor. One peptide tested, E1, induced positive selection on the beta 2M(-/-) background but negative selection on the beta 2M(+/-) background. These results show that the process of positive selection is exquisitely peptide specific and sensitive to extremely low ligand density and support the notion that low efficacy ligands mediate positive selection.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

            The substantia nigra in Parkinson's disease (PD) is depleted of dopaminergic neurons and contains fibrillar Lewy bodies comprising primarily alpha-synuclein. We screened a library to identify drug-like molecules to probe the relation between neurodegeneration and alpha-synuclein fibrilization. All but one of 15 fibril inhibitors were catecholamines related to dopamine. The inhibitory activity of dopamine depended on its oxidative ligation to alpha-synuclein and was selective for the protofibril-to-fibril conversion, causing accumulation of the alpha-synuclein protofibril. Adduct formation provides an explanation for the dopaminergic selectivity of alpha-synuclein-associated neurotoxicity in PD and has implications for current and future PD therapeutic and diagnostic strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells

              Chemokines play a central role in regulating processes essential to the immune function of T cells 1-3 , such as their migration within lymphoid tissues and targeting of pathogens in sites of inflammation. Here we track T cells using multi-photon microscopy to demonstrate that the chemokine CXCL10 enhances the ability of CD8+ T cells to control the pathogen T. gondii in the brains of chronically infected mice. This chemokine boosts T cell function in two different ways: it maintains the effector T cell population in the brain and speeds up the average migration speed without changing the nature of the walk statistics. Remarkably, these statistics are not Brownian; rather, CD8+ T cell motility in the brain is well described by a generalized Lévy walk. According to our model, this surprising feature enables T cells to find rare targets with more than an order of magnitude more efficiency than Brownian random walkers. Thus, CD8+ T cell behavior is similar to Lévy strategies reported in organisms ranging from mussels to marine predators and monkeys 4-10 , and CXCL10 aids T cells in shortening the average time to find rare targets.
                Bookmark

                Author and article information

                Journal
                101528555
                37539
                Nat Commun
                Nat Commun
                Nature communications
                2041-1723
                25 April 2014
                16 April 2014
                2014
                16 October 2014
                : 5
                : 3633
                Affiliations
                [1 ]Department of Neurology, Columbia University Medical Center, New York, NY 10032 USA
                [2 ]Institute of Biomedical Technologies, National Research Council of Italy, 20090 Segrate, Milano, ITALY
                [3 ]Center for Stem Cell Biology, Sloan-Kettering Institute, 10065, New York, New York, USA
                [4 ]The Neurogenomics Laboratory, Harvard Medical School and Brigham and Women’s Hospital, Cambridge, MA 02139
                [5 ]Sloan Kettering Memorial Hospital, New York, NY
                [6 ]New York Brain Bank, Columbia University Medical Center, New York, NY 10032 USA
                [7 ]Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, NY 10032 USA
                [8 ]Department of Psychiatry, Columbia University Medical Center, New York, NY 10032 USA
                [9 ]Department of Pharmacology, Columbia University Medical Center, New York, NY 10032 USA
                Author notes
                [* ]Correspondence should be addressed to: Professor David Sulzer ( ds43@ 123456columbia.edu ), Columbia University Medical Center, 650 West, 168 th Street, William Black Building, Neurology Dept, 3 rd floor, Rm 308, New York City, NY 10032, Phone: +1 212 305 3967, Fax: +1 212 342 3664
                Article
                NIHMS575217
                10.1038/ncomms4633
                4024461
                24736453
                da8c4b73-0af1-46ec-8e5e-2037a68f5fb7
                History
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article